144 related articles for article (PubMed ID: 3079482)
1. How effective is cytotoxic chemotherapy for disseminated prostatic carcinoma?
Eisenberger MA; Kennedy P; Abrams J
Oncology (Williston Park); 1987 Jun; 1(4):59-71. PubMed ID: 3079482
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy: is it effective in treatment of prostatic cancer?
Murphy GP
Urology; 1984 Nov; 24(5 Suppl):41-7. PubMed ID: 6388094
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of advanced cancer of the prostate.
Wirth MP
Prog Clin Biol Res; 1990; 350():159-70. PubMed ID: 2201042
[No Abstract] [Full Text] [Related]
4. [Chemotherapy of prostatic carcinoma].
Wirth M; Altwein JE
Urologe A; 1991 Jan; 30(1):17-24. PubMed ID: 2014582
[TBL] [Abstract][Full Text] [Related]
5. [Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate].
Matveev BP; Bukharkin BV
Vopr Onkol; 1998; 44(5):537-40. PubMed ID: 9884710
[TBL] [Abstract][Full Text] [Related]
6. [Advanced prostate cancer--a therapeutic dilemma?].
Rübben H; Altwein JE
Urologe A; 1987 Jan; 26(1):7-14. PubMed ID: 3576864
[TBL] [Abstract][Full Text] [Related]
7. The role of chemotherapy in the treatment of prostatic carcinoma.
Tonato M; Bracarda S
Rays; 1993; 18(1):87-93. PubMed ID: 8356244
[No Abstract] [Full Text] [Related]
8. A critical assessment of the role of chemotherapy for endocrine-resistant prostatic carcinoma.
Eisenberger MA; Bezerdjian L; Kalash S
Urol Clin North Am; 1987 Nov; 14(4):695-706. PubMed ID: 3314063
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of hormonally unresponsive prostatic carcinoma.
deKernion JB; Lindner A
Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
[TBL] [Abstract][Full Text] [Related]
10. Is chemotherapy ready for clinical use in prostatic cancer patients?
Jones WG
Prog Clin Biol Res; 1988; 269():159-76. PubMed ID: 3293058
[No Abstract] [Full Text] [Related]
11. Management of disseminated disease in the patient with bladder cancer.
Perry JJ; Muss HB
Urol Clin North Am; 1994 Nov; 21(4):661-72. PubMed ID: 7974898
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for prostate cancer - recent progress in clinical trials.
Kipp RT; McNeel DG
Clin Adv Hematol Oncol; 2007 Jun; 5(6):465-74, 477-9. PubMed ID: 17679921
[TBL] [Abstract][Full Text] [Related]
13. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy in cancer of the prostate].
D'Acremont B; Gattegno B; Cohen L; Fiatte P; Lucaks B; Thibault P
Ann Urol (Paris); 1990; 24(2):87-95. PubMed ID: 2190532
[TBL] [Abstract][Full Text] [Related]
15. [Cancer of the prostate: current status of chemotherapy].
Bollak C; Bergerat JP; Jacquemin D
Bull Cancer; 1986; 73(1):61-4. PubMed ID: 3535934
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy in epithelial ovarian cancer.
Wang J; Li AJ; Karlan BY
Curr Womens Health Rep; 2002 Feb; 2(1):20-6. PubMed ID: 12112979
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities and limits of cytostatic chemotherapy in pancreatic carcinoma].
Scheithauer W
Wien Klin Wochenschr; 1994; 106(22):704-8. PubMed ID: 7825320
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of advanced prostatic carcinoma.
Millikan RE
Semin Oncol; 1999 Apr; 26(2):185-91. PubMed ID: 10597729
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for androgen-independent prostate cancer.
Gulley J; Figg WD; Dahut WL
Clin Adv Hematol Oncol; 2003 Jan; 1(1):49-57. PubMed ID: 16227960
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of bicalutamide in adjuvant treatment of prostatic carcinoma after primary therapy with curative aim. The viewpoint of the surgeon].
Rigatti P; Scattoni V
Recenti Prog Med; 2002 Mar; 93(3):183-5. PubMed ID: 11942171
[No Abstract] [Full Text] [Related]
[Next] [New Search]
